InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	4.68	6.57	8.91	6.18	7.36	5.81
Short-Term Investments	0.04	0.04	0.04	0.04	0.05	0.04
Cash & Short-Term Investments	4.72	6.61	8.96	6.22	7.41	5.85
Cash Growth	-38.24%	-26.15%	43.96%	-16.03%	26.70%	-57.46%
Accounts Receivable	0.37	0.35	0.26	0.09	-	-
Other Receivables	-	-	-	-	0.01	0.05
Receivables	0.37	0.35	0.26	0.09	0.01	0.05
Inventory	0.81	1.24	1.62	2.49	-	-
Prepaid Expenses	0.51	0.48	0.5	0.8	0.84	0.13
Other Current Assets	-	-	-	-	0.11	0.29
Total Current Assets	6.41	8.69	11.33	9.6	8.38	6.31
Property, Plant & Equipment	1.11	1.25	0.72	0.9	0.33	0.4
Other Intangible Assets	1.66	1.78	1.95	2.11	1.06	1.09
Other Long-Term Assets	0.1	0.1	0.1	0.18	0.01	-
Total Assets	9.28	11.82	14.11	12.79	9.78	7.8
Accounts Payable	0.56	0.63	0.54	1.17	0.78	0.71
Accrued Expenses	0.85	0.99	1.06	1.25	1.36	0.9
Current Portion of Leases	0.43	0.32	0.38	0.4	0.08	0.07
Other Current Liabilities	0	0.04	0.02	0.5	-	-
Total Current Liabilities	1.84	1.97	2	3.32	2.22	1.68
Long-Term Leases	0.42	0.64	0.02	0.39	0.19	0.25
Total Liabilities	2.26	2.62	2.02	3.71	2.4	1.92
Common Stock	87.46	82.78	77.62	70.72	60.59	53.07
Additional Paid-In Capital	34.89	35.37	35.74	31.68	21.51	17.76
Retained Earnings	-115.45	-109.08	-101.4	-93.45	-74.85	-64.65
Comprehensive Income & Other	0.13	0.13	0.13	0.13	0.13	-0.3
Shareholders' Equity	7.02	9.21	12.09	9.08	7.38	5.88
Total Liabilities & Equity	9.28	11.82	14.11	12.79	9.78	7.8
Total Debt	0.85	0.96	0.39	0.79	0.27	0.32
Net Cash (Debt)	3.87	5.65	8.57	5.43	7.14	5.53
Net Cash Growth	-41.09%	-34.01%	57.80%	-23.98%	29.08%	-59.76%
Net Cash Per Share	5.36	14.83	69.96	193.57	531.24	529.76
Filing Date Shares Outstanding	1.21	0.67	0.17	0.05	0.02	0.01
Total Common Shares Outstanding	1.21	0.45	0.17	0.03	0.02	0.01
Working Capital	4.57	6.72	9.33	6.28	6.16	4.64
Book Value Per Share	5.82	20.64	72.65	279.06	458.14	563.00
Tangible Book Value	5.36	7.42	10.14	6.97	6.31	4.79
Tangible Book Value Per Share	4.44	16.65	60.95	214.23	392.20	458.93
Machinery	0.43	0.47	0.48	0.25	0.07	0.06
Leasehold Improvements	-	-	-	-	0.04	0.04

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q